Literature DB >> 15018470

Nosocomial infections in HIV-positive patients: an overview.

N Petrosillo1, L Pagani, G Ippolito.   

Abstract

Nosocomial infections (NIs) constitute a significant public health problem and contribute to prolonged hospitalization, additional healthcare costs and excess morbidity and mortality. NIs appear to be more common in patients with acquired immunodeficiency syndrome (AIDS) as a result of some degree of immunosuppression, prior antiobiotics treatment and greater exposure to invasive devices such as indwelling intravenous catheters. The objective of this article is to give an insight into the main NIs occurring in HIV-infected patients. Literature pertaining to NIs in HIV-infected patients was reviewed. According to the leading studies in the literature, the incidence of NI ranges from 7.9 to 15 per 100 admissions. Bloodstream infections are the most frequent infections, mainly due to intravascular catheters, followed by urinary and respiratory tract infections. Colonization seems to have an important role in the development of NIs among this immunocompromised population. CLinicians need to be aware of the risk of NIs in HIV-infected patients, and must always take these infections into account in their overall management.

Entities:  

Mesh:

Year:  2003        PMID: 15018470

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  6 in total

Review 1.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.

Authors:  Jared A Greenberg; Jeffrey L Lennox; Greg S Martin
Journal:  J Crit Care       Date:  2011-10-26       Impact factor: 3.425

3.  Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients.

Authors:  André M Japiassú; Rodrigo T Amâncio; Emerson C Mesquita; Denise M Medeiros; Helena B Bernal; Estevão P Nunes; Paula M Luz; Beatriz Grinsztejn; Fernando A Bozza
Journal:  Crit Care       Date:  2010-08-10       Impact factor: 9.097

Review 4.  Urological aspects of HIV and AIDS.

Authors:  Chris F Heyns; Shaun G Smit; André van der Merwe; Amir D Zarrabi
Journal:  Nat Rev Urol       Date:  2013-10-29       Impact factor: 14.432

5.  AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial.

Authors:  Sakib Burza; Raman Mahajan; Shahwar Kazmi; Neal Alexander; Deepak Kumar; Vikash Kumar; Estrella Lasry; Amit Harshana; Alan de Lima Pereira; Pradeep Das; Neena Verma; Vidya Nand Ravi Das; Chandra Shekhar Lal; Bharat Rewari; Vishal Goyal; Suman Rijal; Fabiana Alves; Naresh Gill; Krishna Pandey
Journal:  Clin Infect Dis       Date:  2022-10-12       Impact factor: 20.999

6.  Nosocomial infections in human immunodeficiency virus type 1 (HIV-1) infected and AIDS patients: major microorganisms and immunological profile.

Authors:  C Panis; T Matsuo; E M V Reiche
Journal:  Braz J Microbiol       Date:  2009-03-01       Impact factor: 2.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.